skip to main content

Melanoma

Immunotherapy cancer drugs may impact vision

Date Visible: 
Wednesday, May 9, 2018 - 15:30
Although it is rare, knowledge of this risk is important both for the ophthalmologists who treat it and for the oncologists prescribing the anti-cancer treatment, say Michigan Medicine researchers. The cases of three recent patients, published in JAMA Ophthalmology, highlight the issue. Patients receiving immune checkpoint inhibitors developed uveal effusions and eye inflammation that affected their vision.

Genetic Risk Factors for Skin Cancer

Many factors can increase the risk of developing melanoma and other skin cancers. Some of these factors are due to behaviors, like exposure to the sun. However, some risk factors for skin cancers are inherited in families.

Pages